Effect of ZD1839 on Bladder Cancer Cells and Radiation
Author Information
Author(s): Maddineni S B, Sangar V K, Hendry J H, Margison G P, Clarke N W
Primary Institution: Cancer Research-UK Carcinogenesis Group, Paterson Institute for Cancer Research
Hypothesis
Can ZD1839 enhance the effectiveness of radiation therapy in bladder cancer cell lines?
Conclusion
ZD1839 significantly enhances the radiosensitivity of bladder cancer cells, suggesting its potential as an adjuvant in radiotherapy.
Supporting Evidence
- ZD1839 showed a highly significant radiosensitising effect on both bladder cancer cell lines.
- The combination of ZD1839 and radiation resulted in a marked induction of apoptosis in both cell lines.
- Cell cycle kinetics were not significantly altered by ZD1839 treatment.
Takeaway
This study found that a drug called ZD1839 can help make radiation therapy work better for bladder cancer cells.
Methodology
The study used clonogenic assays to measure the effects of ZD1839 and radiation on bladder cancer cell lines.
Limitations
The study was conducted in vitro, and results may not fully translate to in vivo conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website